Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 47 | 0 | 4 | 0 | €696.50 | €754.73 | 8.360% |
| Vertex Pharmaceuticals Inc. | 40 | 2 | 5 | 0 | €378.45 | €382.71 | 1.124% |
| Alnylam Pharmace. | 35 | 0 | 3 | 0 | €136.05 | €236.30 | 73.685% |
| Regeneron Pharmaceuticals Inc. | 32 | 1 | 6 | 1 | €851.20 | €954.29 | 12.112% |
| Johnson & Johnson | 32 | 1 | 2 | 0 | €140.04 | €196.74 | 40.485% |
| Merck & Co. Inc. | 27 | 1 | 4 | 0 | €118.40 | €124.92 | 5.503% |
| Pfizer Inc. | 30 | 4 | 3 | 1 | €24.56 | €41.29 | 68.109% |
| Trinity Biotech ADR | 24 | 0 | 3 | 0 | €0.41 | - | - |
| Amgen Inc. | 23 | 0 | 3 | 0 | €256.50 | €293.65 | 14.482% |
| Cytokinetics Inc. | 24 | 1 | 3 | 0 | €64.00 | €86.72 | 35.492% |
| Intra-Cellular Therapies Inc. | 22 | 0 | 7 | 0 | €70.00 | €79.29 | 13.274% |
| Neurocrine Bioscience | 21 | 0 | 1 | 0 | €136.05 | €137.10 | 0.772% |
| Natural Alternat. | 19 | 1 | 2 | 0 | €6.00 | - | - |
| BioMarin Pharmaceutical Inc. | 18 | 0 | 0 | 0 | €84.10 | €102.48 | 21.850% |
| Sutro Biopharma Inc | 18 | 0 | 7 | 0 | €3.36 | €11.05 | 228.821% |
| AbbVie Inc. | 18 | 1 | 2 | 1 | €157.92 | €175.79 | 11.315% |
| Novo Nordisk A/S ADR | 17 | 1 | 3 | 0 | €119.50 | €130.22 | 8.970% |
| TG Therapeutics Inc. | 20 | 4 | 3 | 0 | €13.37 | €26.00 | 94.509% |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 1 | €11.11 | €22.78 | 105.090% |
| Abbott Laboratories | 16 | 0 | 4 | 0 | €100.62 | €116.81 | 16.088% |
| Krystal Biotech | 16 | 0 | 3 | 0 | €152.20 | €173.22 | 13.810% |
| United Therapeutics | 15 | 0 | 0 | 0 | €222.00 | €289.92 | 30.595% |
| Exelixis Inc. | 15 | 0 | 0 | 0 | €21.74 | €26.01 | 19.625% |
| Icon plc | 15 | 0 | 3 | 0 | €281.70 | €318.32 | 13.000% |
| Stoke Therapeutics Inc | 15 | 1 | 7 | 0 | €10.60 | €21.39 | 101.821% |